For atrial fibrillation ablation, newer anticoagulant reduces major bleeds
Uninterrupted treatment with dabigatran, a non-vitamin K antagonist oral anticoagulant (NOACs), before, during and after ablation to treat atrial fibrillation significantly reduced the incidence of major bleeding events compared ...
Mar 20, 2017
0
0